Thompson Peter A. (CIK 0001357522)

Latest company ownership

Shares held
4,901,310
Last filed at
Jun 6, 2018
Confidence Score
50.0
2025Q4
Confidence Score History
2016Q2 2025Q4
Shares held
3,596,886
Last filed at
Nov 26, 2025
Confidence Score
24.3
2025Q4
Confidence Score History
2025Q1 2025Q4
Shares held
1,397,684
Last filed at
Jul 1, 2025
Confidence Score
48.5
2025Q4
Confidence Score History
2016Q1 2025Q4
Shares held
538,646
Last filed at
Dec 3, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q4 2025Q4
Shares held
443,792
Last filed at
Apr 4, 2025
Confidence Score
52.1
2025Q4
Confidence Score History
2021Q1 2025Q4
Shares held
231,098
Last filed at
Dec 30, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q2 2025Q4
Shares held
16,333
Last filed at
Jun 9, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 17, 2025 Dec 19, 2025 Sionna Therapeutics, Inc. Director Sell 47.5 -1,875 -0.05% ✗ $83.4K
Nov 24, 2025 Nov 26, 2025 Sionna Therapeutics, Inc. Director Sell 17.5 -108,073 -2.92% ✗ $4.8M
Jun 27, 2025 Jul 1, 2025 Corvus Pharmaceuticals, Inc. Director Sell 17.5 -1,176,332 -14.10% ✗ $4.9M
Apr 3, 2025 Apr 4, 2025 Edgewise Therapeutics, Inc. Director Buy 95.0 +496,771 3.37% ✗ $10M
Feb 10, 2025 Feb 10, 2025 Sionna Therapeutics, Inc. Director Buy 100.0 +550,000 17.43% ✗ $9.9M
Aug 26, 2024 Aug 28, 2024 ARS Pharmaceuticals, Inc. Director Sell 17.5 -83,695 -100.00% ✗ $1.1M
Aug 21, 2024 Aug 23, 2024 ARS Pharmaceuticals, Inc. Director Sell 15.0 -868,682 -91.21% ✗ $11.5M
Jan 23, 2024 Jan 25, 2024 Edgewise Therapeutics, Inc. Director Buy 92.5 +454,545 3.25% ✗ $5M
Aug 29, 2023 Aug 31, 2023 ARS Pharmaceuticals, Inc. Director Buy 95.0 +500,000 6.65% ✗ $3.1M
Sep 16, 2022 Sep 16, 2022 Edgewise Therapeutics, Inc. Director Buy 92.5 +484,496 3.59% ✗ $5M
May 18, 2022 May 20, 2022 Edgewise Therapeutics, Inc. Director Buy 85.0 +138,000 1.03% ✗ $995K
Dec 29, 2021 Dec 30, 2021 Janux Therapeutics, Inc. Director Sell 20.0 -40,400 -1.60% ✗ $820.1K
Dec 21, 2021 Dec 23, 2021 Janux Therapeutics, Inc. Director Sell 17.5 -119,400 -4.51% ✗ $2.3M
Dec 16, 2021 Dec 17, 2021 Janux Therapeutics, Inc. Director Sell 16.3 -393,300 -12.93% ✗ $7.5M
Sep 20, 2021 Sep 22, 2021 Corvus Pharmaceuticals, Inc. Director Sell 16.3 -1,109,644 -13.78% ✗ $6.8M
Jun 15, 2021 Jun 16, 2021 Janux Therapeutics, Inc. Director Buy 100.0 +705,853 30.20% ✗ $12M
Mar 30, 2021 Mar 31, 2021 Edgewise Therapeutics, Inc. Director Buy 93.8 +359,375 2.70% ✗ $5.8M
Feb 17, 2021 Feb 19, 2021 Corvus Pharmaceuticals, Inc. Director Buy 100.0 +1,285,714 19.00% ✗ $4.5M
Dec 8, 2020 Dec 8, 2020 ARS Pharmaceuticals, Inc. Director Buy 100.0 +1,190,477 221.01% ✗ $25M
Sep 25, 2020 Sep 29, 2020 PMV Pharmaceuticals, Inc. Director Buy 100.0 +950,000 100.00% ✗ $17.1M
Aug 6, 2019 Aug 8, 2019 Corvus Pharmaceuticals, Inc. Director Buy 85.0 +142,656 2.15% ✗ $500.7K
Jun 27, 2019 Jul 1, 2019 Corvus Pharmaceuticals, Inc. Director Buy 100.0 +657,344 11.02% ✗ $2.4M
Jun 4, 2018 Jun 6, 2018 Adaptimmune Therapeutics PLC Director Sell 37.5 -18,700 -0.38% ✗ $253.6K
May 30, 2018 Jun 1, 2018 Adaptimmune Therapeutics PLC Director Sell 17.5 -171,000 -3.36% ✗ $2.3M
May 14, 2018 May 16, 2018 Adaptimmune Therapeutics PLC Director Sell 40.0 -10,300 -0.20% ✗ $139.1K
Mar 27, 2018 Mar 29, 2018 Adaptimmune Therapeutics PLC Director Sell 15.0 -1,048,067 -17.04% ✗ $12.1M
Mar 12, 2018 Mar 14, 2018 Corvus Pharmaceuticals, Inc. Director Buy 100.0 +588,235 10.94% ✗ $5M
Mar 27, 2017 Mar 28, 2017 Adaptimmune Therapeutics PLC Director Buy 100.0 +1,190,476 24.01% ✗ $5M
Jun 23, 2016 Jun 27, 2016 Corvus Pharmaceuticals, Inc. Director Buy 48.8 +1,000 0.02% ✗ $13K
Jun 17, 2016 Jun 21, 2016 Corvus Pharmaceuticals, Inc. Director Buy 75.0 +38,383 0.72% ✗ $489.2K
Jun 14, 2016 Jun 16, 2016 Corvus Pharmaceuticals, Inc. Director Buy 65.0 +20,000 0.38% ✗ $247K
Jun 9, 2016 Jun 13, 2016 Corvus Pharmaceuticals, Inc. Director Buy 75.0 +50,000 0.95% ✗ $648.1K
May 20, 2016 May 25, 2016 Adaptimmune Therapeutics PLC Director Buy 97.5 +1,712,400 6.11% ✗ $17.8M
May 20, 2016 May 24, 2016 Corvus Pharmaceuticals, Inc. Director Buy 60.0 +4,716 0.09% ✗ $61.7K
May 18, 2016 May 20, 2016 Corvus Pharmaceuticals, Inc. Director Buy 60.0 +6,800 0.13% ✗ $80K
Mar 29, 2016 Mar 29, 2016 Corvus Pharmaceuticals, Inc. Director Buy 100.0 +550,000 11.68% ✗ $8.3M